Prev Close | 96.25 |
Open | 96.06 |
Day Low/High | 96.06 / 99.97 |
52 Wk Low/High | 82.49 / 209.00 |
Volume | 459.71K |
Prev Close | 96.25 |
Open | 96.06 |
Day Low/High | 96.06 / 99.97 |
52 Wk Low/High | 82.49 / 209.00 |
Volume | 459.71K |
Exchange | NASDAQ |
Shares Outstanding | 71.01B |
Market Cap | 6.87B |
Div & Yield | N.A. (N.A) |
This is one of those days when it may pay to walk away.
Biotechnology is showing little relative strength and oil is up again, but there isn't much going on with themes.
Since the Caribbean biopharm launched its IPO last June, half its market cap seems to have vanished somewhere in the Bermuda Triangle.
Garvis Toler, head of global capital markets at the NYSE, reviews the landscape of IPOs during the first half of 2015 and previews what's in store for the second half.
There may be more volatility where this came from.